BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7661176)

  • 1. Modulation of gallbladder contraction by pirenzepine in humans.
    Yeğen B; Biren T; Onat F; Tankurt E; Gürmen N; Oktay S; Chey WY; Ulusoy NB
    Am J Gastroenterol; 1995 Sep; 90(9):1489-94. PubMed ID: 7661176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pirenzepine on gallbladder contraction in man induced by sham feeding or an intraduodenal meal.
    Tankurt E; Yegen BC; Biren T; Gürmen N; Onat F; Erçil A; Oktay S; Ulusoy NB
    Digestion; 1992; 51(2):103-9. PubMed ID: 1499872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans.
    Nelson DK; Glasbrenner B; Dahmen G; Riepl RL; Malfertheiner P; Adler G
    Am J Physiol; 1996 Nov; 271(5 Pt 1):G824-30. PubMed ID: 8944697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal phytohaemagglutinin (red kidney bean lectin) stimulates gallbladder contraction in humans.
    Purhonen AK; Herzig KH; Gabius HJ; André S; Ketterer S; Matzinger D; Beglinger C; Hildebrand P
    Acta Physiol (Oxf); 2008 Jul; 193(3):241-7. PubMed ID: 18248661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholecystokinin-induced gallbladder contraction by atropine and pirenzepine in man.
    Yegen BC; Tankurt E; Gürmen N; Bayram M; Oktay S; Ulusoy NB
    Digestion; 1990; 45(3):176-80. PubMed ID: 2373273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
    Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
    Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B; Mawe GM; Riepl RL
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.
    Shirohara H; Tabaru A; Otsuki M
    J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cholecystokinin release and gallbladder contraction between emulsified and nonemulsified long-chain triglycerides.
    Ledeboer M; Masclee AA; Biemond I; Lamers CB
    JPEN J Parenter Enteral Nutr; 1999; 23(4):203-6. PubMed ID: 10421388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin induced gallbladder contraction is influenced by nicotinic and muscarinic receptors.
    Pozo MJ; Salido GM; Madrid JA
    Arch Int Physiol Biochim; 1989 Oct; 97(5):403-8. PubMed ID: 2480096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder emptying and cholecystokinin and pancreatic polypeptide responses to a liquid meal in patients with diabetes mellitus.
    Meguro T; Shimosegawa T; Satoh A; Suzuki H; Takasu A; Takayama A; Koizumi M; Toyota T
    J Gastroenterol; 1997 Oct; 32(5):628-34. PubMed ID: 9349988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-induced gallbladder contraction and muscarinic blockade with pirenzepine in man.
    Ulusoy NB; Oktay S; Yegen BC; Tankurt E; Gurmen N
    Dig Dis Sci; 1995 Feb; 40(2):427. PubMed ID: 7851210
    [No Abstract]   [Full Text] [Related]  

  • 14. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
    Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
    Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elemental diet stimulates gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide in man.
    Hopman WP; de Jong AJ; Rosenbusch G; Jansen JB; Lamers CB
    Dig Dis Sci; 1987 Jan; 32(1):45-9. PubMed ID: 3539560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system.
    Hopman WP; Jansen JB; Rosenbusch G; Lamers CB
    Digestion; 1987; 38(4):197-203. PubMed ID: 3447914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder motility in response to sham feeding and cholecystokinin in lean and obese subjects.
    Masclee AA; Gielkens HA; Lieverse RJ; Penning C; Schipper J; Lamers CB
    Digestion; 1997; 58(1):43-9. PubMed ID: 9018009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder dynamics and plasma cholecystokinin responses after meals, oral water, or sham feeding in healthy subjects.
    Yamamura T; Takahashi T; Kusunoki M; Kantoh M; Seino Y; Utsunomiya J
    Am J Med Sci; 1988 Feb; 295(2):102-7. PubMed ID: 3344757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition.
    Ledeboer M; Masclee AA; Biemond I; Lamers CB
    Am J Gastroenterol; 1997 Dec; 92(12):2274-9. PubMed ID: 9399769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.